ELLIOTT ASSOCIATES LP Insider Trading $VION VION PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ELLIOTT ASSOCIATES LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ELLIOTT ASSOCIATES LP. ELLIOTT ASSOCIATES LP is 10% Owner in Arconic Inc. ($AA) and 10% Owner in EMULEX CORP /DE/ ($ELX) and in CITRIX SYSTEMS INC ($CTXS) and 10% Owner in ISCO INTERNATIONAL INC ($ISO) and Director in ISCO INTERNATIONAL INC ($ISO) and 10% Owner in VION PHARMACEUTICALS INC ($VION) and Director in VION PHARMACEUTICALS INC ($VION) and 10% Owner in HORIZON OFFSHORE INC ($HOFF) and 10% Owner in PEABODY ENERGY CORP ($BTU) and 10% Owner in MITEL NETWORKS CORP ($MITL) and 10% Owner in ROAN RESOURCES, INC. ($LINE) and 10% Owner in Affinion Group Holdings, Inc. ($AGHI) and 10% Owner in Roadrunner Transportation Systems, Inc. ($RRTS) and 10% Owner in National Bank Holdings Corp ($NBHC).
ELLIOTT ASSOCIATES LP in VION PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ELLIOTT ASSOCIATES LP: Director, 10% Owner
Holdings: 0 shares
Latest Transaction: Sep 13 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ELLIOTT ASSOCIATES LP in VION PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGHI, CTXS, ELX, HOFF, ARNC, ISO, MITL, NBHC, BTU, LINE, RRTS, VION
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 13 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.88 | 12,500 | 48,500 | 0 | 12.5 K to 0 (-100.00 %) |
| Sep 13 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.86 | 19,221 | 74,193 | 12,500 | 31.7 K to 12.5 K (-60.59 %) |
| Sep 09 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.90 | 5,000 | 19,500 | 68,971 | 74 K to 69 K (-6.76 %) |
| Sep 09 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.85 | 48,971 | 188,538 | 73,971 | 122.9 K to 74 K (-39.83 %) |
| Sep 10 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.88 | 12,250 | 47,530 | 31,721 | 44 K to 31.7 K (-27.86 %) |
| Sep 10 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.89 | 25,000 | 97,250 | 43,971 | 69 K to 44 K (-36.25 %) |
| Sep 08 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.93 | 12,000 | 47,160 | 122,942 | 134.9 K to 122.9 K (-8.89 %) |
| Sep 08 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.00 | 11,519 | 46,076 | 134,942 | 146.5 K to 134.9 K (-7.86 %) |
| Sep 07 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.74 | 10,000 | 37,400 | 146,461 | 156.5 K to 146.5 K (-6.39 %) |
| Sep 07 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.88 | 60,080 | 233,110 | 156,461 | 216.5 K to 156.5 K (-27.75 %) |
| Sep 03 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.70 | 10,000 | 37,000 | 216,541 | 226.5 K to 216.5 K (-4.41 %) |
| Sep 03 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.69 | 10,000 | 36,900 | 226,541 | 236.5 K to 226.5 K (-4.23 %) |
| Sep 02 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.53 | 6,000 | 21,180 | 236,541 | 242.5 K to 236.5 K (-2.47 %) |
| Sep 01 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.58 | 2,000 | 7,160 | 242,541 | 244.5 K to 242.5 K (-0.82 %) |
| Aug 31 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.55 | 10,000 | 35,500 | 244,541 | 254.5 K to 244.5 K (-3.93 %) |
| Aug 30 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.67 | 18,823 | 69,080 | 254,541 | 273.4 K to 254.5 K (-6.89 %) |
| Aug 30 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.70 | 1,000 | 3,700 | 273,364 | 274.4 K to 273.4 K (-0.36 %) |
| Aug 27 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.60 | 33,000 | 118,800 | 274,364 | 307.4 K to 274.4 K (-10.74 %) |
| Aug 27 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.65 | 5,310 | 19,382 | 307,364 | 312.7 K to 307.4 K (-1.70 %) |
| Aug 25 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.60 | 17,000 | 61,200 | 312,674 | 329.7 K to 312.7 K (-5.16 %) |
| Aug 25 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.61 | 100 | 361 | 329,674 | 329.8 K to 329.7 K (-0.03 %) |
| Aug 24 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.60 | 3,390 | 12,204 | 329,774 | 333.2 K to 329.8 K (-1.02 %) |
| Aug 24 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.50 | 121,141 | 423,994 | 333,164 | 454.3 K to 333.2 K (-26.67 %) |
| Aug 23 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.50 | 2,100 | 7,350 | 454,305 | 456.4 K to 454.3 K (-0.46 %) |
| Aug 20 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.53 | 26,130 | 92,239 | 456,405 | 482.5 K to 456.4 K (-5.42 %) |
| Aug 20 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.70 | 6,453 | 23,876 | 482,535 | 489 K to 482.5 K (-1.32 %) |
| Jun 16 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.05 | 3,500 | 14,175 | 488,988 | 492.5 K to 489 K (-0.71 %) |
| Jun 16 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.00 | 5,192 | 20,768 | 492,488 | 497.7 K to 492.5 K (-1.04 %) |
| Jun 15 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.05 | 35,304 | 142,981 | 497,680 | 533 K to 497.7 K (-6.62 %) |
| Jun 15 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.04 | 62,600 | 252,904 | 532,984 | 595.6 K to 533 K (-10.51 %) |
| Jun 15 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.03 | 63,100 | 254,293 | 595,584 | 658.7 K to 595.6 K (-9.58 %) |
| Jun 10 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.00 | 13,012 | 52,048 | 658,684 | 671.7 K to 658.7 K (-1.94 %) |
| Jun 09 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.06 | 11,554 | 46,909 | 671,696 | 683.3 K to 671.7 K (-1.69 %) |
| Jun 09 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.07 | 28,520 | 116,076 | 683,250 | 711.8 K to 683.3 K (-4.01 %) |
| Jun 09 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.07 | 18,000 | 73,260 | 711,770 | 729.8 K to 711.8 K (-2.47 %) |
| Jun 08 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.09 | 6,396 | 26,160 | 729,770 | 736.2 K to 729.8 K (-0.87 %) |
| Jun 08 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.10 | 18,280 | 74,948 | 736,166 | 754.4 K to 736.2 K (-2.42 %) |
| Jun 07 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.10 | 24,400 | 100,040 | 754,446 | 778.8 K to 754.4 K (-3.13 %) |
| Jun 04 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.06 | 15,903 | 64,566 | 778,846 | 794.7 K to 778.8 K (-2.00 %) |
| Jun 04 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.22 | 10,000 | 42,200 | 794,749 | 804.7 K to 794.7 K (-1.24 %) |
| Jun 03 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.04 | 25,001 | 101,004 | 804,749 | 829.8 K to 804.7 K (-3.01 %) |
| Jun 02 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.83 | 93,208 | 356,987 | 829,750 | 923 K to 829.8 K (-10.10 %) |
| Jun 02 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 3.84 | 65,200 | 250,368 | 922,958 | 988.2 K to 923 K (-6.60 %) |
| Jun 01 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.21 | 28,520 | 120,069 | 988,158 | 1 M to 988.2 K (-2.81 %) |
| Jun 01 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.23 | 20,000 | 84,600 | 1,016,678 | 1 M to 1 M (-1.93 %) |
| Jun 01 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.20 | 23,307 | 97,889 | 1,036,678 | 1.1 M to 1 M (-2.20 %) |
| May 28 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.20 | 69,000 | 289,800 | 1,059,985 | 1.1 M to 1.1 M (-6.11 %) |
| May 28 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.21 | 80,000 | 336,800 | 1,128,985 | 1.2 M to 1.1 M (-6.62 %) |
| May 27 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.17 | 20,000 | 83,400 | 1,208,985 | 1.2 M to 1.2 M (-1.63 %) |
| May 27 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.17 | 20,000 | 83,400 | 1,228,985 | 1.2 M to 1.2 M (-1.60 %) |
| May 26 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.26 | 15,160 | 64,582 | 1,248,985 | 1.3 M to 1.2 M (-1.20 %) |
| May 26 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.20 | 32,000 | 134,400 | 1,264,145 | 1.3 M to 1.3 M (-2.47 %) |
| May 25 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | Director | Sell | S | 4.34 | 25,100 | 108,934 | 1,296,145 | 1.3 M to 1.3 M (-1.90 %) |
| May 24 2004 | VION | VION PHARMACEUTICA ... | ELLIOTT ASSOCIATES LP | 10% Owner | Sell | S | 4.45 | 160,599 | 714,666 | 1,321,245 | 1.5 M to 1.3 M (-10.84 %) |
Page: 1